A detailed history of Kempen Capital Management N.V. transactions in Boston Scientific Corp stock. As of the latest transaction made, Kempen Capital Management N.V. holds 101,260 shares of BSX stock, worth $10.1 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
101,260
Holding current value
$10.1 Million
% of portfolio
0.11%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 07, 2025

BUY
$89.7 - $107.41 $9.08 Million - $10.9 Million
101,260 New
101,260 $10.9 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $143B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Kempen Capital Management N.V. Portfolio

Follow Kempen Capital Management N.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kempen Capital Management N.V., based on Form 13F filings with the SEC.

News

Stay updated on Kempen Capital Management N.V. with notifications on news.